๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Single-dose versus fractionated-dose dactinomycin in the treatment of wilms' tumor. Preliminary results of a clinical trial

โœ Scribed by Beatriz De Camargo; Eduardo L. Franco; The Brazilian Wilms' Tumor Study Group


Publisher
John Wiley and Sons
Year
1991
Tongue
English
Weight
685 KB
Volume
67
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


A randomized clinical trial of single-do
โœ Beatriz De Camargo; Eduardo L. Franco; Brazilian Wilms' Tumor Study Group ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 500 KB

for the Brazilian Wilms' Tumor Study Group$ Background. To verify the adequacy of a simplified chemotherapeutic regimen for the treatment of Wilms' tumor (WT), the authors conducted a clinical trial to compare the standard fractionated dose (15 mcg/kg x 5 days) of dactinomycin (AMD) with a single do

Dose-ranging study of mesalamine (PENTAS
โœ Dr. Stephen B. Hanauer ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 490 KB

The safety and efficacy of mesalamine enemas were determined in a dose-ranging study enrolling 287 patients with ulcerative proctitis and proctosigmoiditis in a doubleblind, placebo-controlled, multicenter trial. Patients were randomized to receive placebo, 1, 2, or 4 g in 100 ml mesalamine (PENTASA